• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

medRxiv [Preprint]. Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history

tetano

Editor, Senior Moderator
medRxiv


[Preprint]. 2025 Sep 4:2025.09.02.25334929.
doi: 10.1101/2025.09.02.25334929. Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history

Jordan T Ort[SUP] 1 [/SUP], Ashley Sobel Leonard[SUP] 1 2 [/SUP], Shuk Hang Li[SUP] 1 [/SUP], Reilly K Atkinson[SUP] 1 [/SUP], Lydia M Mendoza[SUP] 1 [/SUP], Marcos Costa Vieira[SUP] 3 [/SUP], Sydney Gang[SUP] 1 [/SUP], Sarah Cobey[SUP] 3 [/SUP], Scott E Hensley[SUP] 1 [/SUP]



Affiliations
Abstract

H5N1 highly pathogenic avian influenza viruses have spread globally and pose a risk for a human pandemic. Prior studies suggest that early life exposures to group 1 influenza viruses (H1N1 and H2N2) prime antibodies that cross-react to the hemagglutinin of H5N1, which is also a group 1 virus. Less is known about how immune history affects antibody responses against the neuraminidase (NA) of H5N1 viruses. Here, we measured NA inhibition antibodies against multiple H5N1 viruses using sera from 155 individuals born between 1927 and 2016. We found that individuals primed in childhood with H1N1 viruses were more likely to possess higher levels of antibodies that cross-react with the NA of H5N1 viruses compared to individuals primed in childhood with H2N2 or H3N2 viruses. While young children rarely possessed cross-reactive NA antibodies, we found that childhood infections with contemporary H1N1, but not H3N2, viruses can elicit them. These data suggest that immune history greatly impacts the generation of cross-reactive NA antibodies that can inhibit H5N1 viruses.


 
Back
Top Bottom